The octogenarian allergist, who had been with the government since 1968 and appointed head of the NIH’s infectious disease arm by former ... with fireworks outlets geared toward out-of-state visitors, ...

Officials are warning of "unprecedented traffic" as the Bethesda Main Campus sees the first day of return-to-office mandate.

In October, Jay Bhattacharya, then a health economist at Stanford University, posted on X: “If you favor government control of misinformation, you are an enemy of free speech.” On Wednesday ...

The full Senate voted Tuesday evening to confirm President Donald Trump's pick to lead the National Institutes of Health (NIH), Dr. Jay Bhattacharya. The party-line vote followed approval from the ...

During Donald Trump’s first term, he made it a goal to end the HIV epidemic in the U.S. by 2030. That priority has fallen by the wayside in the second Trump administration, with the termination ...

President Donald Trump's pick to be the next Director of the National Institutes of Health (NIH), Dr. Jay Bhattacharya, spent much of his confirmation hearing Wednesday defending the president's ...

Jay Bhattacharya, a Stanford University health economist who gained notoriety for his criticism of the NIH’s handling of the COVID-19 pandemic, secured the confirmation with a 53-to-47 party-line vote ...

Biology professor Dominique Bergmann was researching background information for her BIO82: Genetics lecture when she realized her access to a National Institutes of Health (NIH) website was blocked.

The Senate on Tuesday confirmed health researcher Jay Bhattacharya as the next leader of the National Institutes of Health (NIH). Bhattacharya was confirmed on a party- line vote, 53 to 47.

DOGE staff met with career officials as recently as Friday afternoon to reiterate the directive, which included an instruction to develop plans that would reset staffing levels to those NIH ...

“I’ve been told that you have said that we need to invest NIH resources into looking at a possible link between measles vaccine and autism. I’ve not heard that directly; it’s hearsa ...

Perspective from Robert F Garry Jr., PhD The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which ...